Highlighting Rising Cannabis Companies

HENDERSON, NV / ACCESSWIRE / March 19, 2019 / From a dirty little secret to one of the fastest growing industries in the world, cannabis has come a long way. As more states are legalizing medical marijuana and recreational marijuana sales and usage, the market will continue to grow.

One drawback of such a hot industry is that the well-known companies generally end up at or above proper valuation quickly. That's why we're highlighting a few companies just starting to gain their actual valuation. THC Therapeutics, Inc. (THCT) said the US patent office has accepted ALL 20 claims for their herb dryer the dHydronator, which can reduce moisture content of Cannabis to 10% in only 10-14 hours. The dHydronator® also destroys harmful surface contaminants & pathogens. So, start your research today.

Today we are highlighting: THC Therapeutics, Inc. (THCT), Aurora Cannabis, Inc. (ACB), 1933 Industries Inc. (TGIFF), Helix TCS Inc. (HLIX) and Cronos Group, Inc. (CRON).

THC Therapeutics, Inc. (THCT) (Market Cap: $88.547M; Share Price: $6.73) has developed a sanitizing herb dryer, The dHydronator®. Their laboratory-proven product is specifically designed for drying and sanitizing freshly harvested Cannabis and herbs. THCT’s product has been tested by two independent laboratories. The testing covered over 6 strains and 9 independent tests to confirm the findings.

As we mentioned earlier, the US patent office has accepted ALL 20 claims for The dHydronator®. This is big. Start your research today.

Aurora Cannabis, Inc. (ACB) (Market Cap: $10.07B; Share Price: $9.94) led a rally in cannabis stocks Wednesday after the company said it is hiring hedge-fund manager, Nelson Peltz, as an adviser with the aim of sealing new cooperation agreements and expanding globally. The Canadian cannabis stock lit up in Wednesday's trading, riding the smoking hot stock action to become the world's second most valuable cannabis company after the advisory announcement.

1933 Industries Inc. (TGIFF) (Market Cap: $98.989M; Share Price: $0.4142), a licensed cultivator and producer of cannabis flower and concentrates and manufacturer of hemp-derived CBD wellness products, closed its previously announced non-brokered private placement which raised total proceeds to the Company of CDN$4.5 million.

Helix TCS Inc. (HLIX) (Market Cap: $165.505M; Share Price: $2.23) is a leading provider of ancillary services for the legal cannabis industry with over 2,000 customer locations in 33 US states and six countries around the world. With a proprietary technology suite and security service offerings, the company has processed over $18 billion in cannabis sales and helped countless businesses remain compliant with evolving government regulations. As new international markets open up, the company is well positioned to leverage its success in the most dominant global cannabis industries, ultimately creating significant barriers to competition.

Cronos Group, Inc. (CRON) (Market Cap: $3.891B; Share Price: $21.69) announced that the C$2.4 billion equity investment in the company by Altria Group, Inc. (NYSE:MO) ("Altria") has closed. As previously announced, Altria's investment represents an approximate 45% ownership interest in Cronos Group. Altria also has a warrant to acquire additional ownership in Cronos Group, which is exercisable over the next four years. If exercised in full today, the warrant would increase Altria's ownership in Cronos Group to approximately 55% and provide Cronos Group with additional proceeds of approximately C$1.4 billion.

Signed by -

Priyanka Goel, CFA

Legal Disclaimer:

This article was written by Regal Consulting, LLC ("Regal Consulting"). Regal Consulting has agreed to a three-month term consulting agreement with THCT dated 2/14/18. The agreement calls for 50,000 restricted shares of THCT per month. All payments were made directly by THC Therapeutics, Inc. to Regal Consulting, LLC. to provide investor relations services, of which this article is a part of. Regal Consulting also paid one thousand dollars cash to microcapspeculators.com to distribute this article. Regal Consulting may have a position in the securities mentioned in this article at the time of publication, and may increase or decrease its position without notice. This article is based on public information and the opinions of Regal Consulting. THCT was given an opportunity to edit this article. This article contains forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any results predicted herein. Regal Consulting is not registered with any financial or securities regulatory authority, and does not provide or claim to provide investment advice.